Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy (Journal of Clinical Investigation, 2019)

(untitled) - Roberts, JD; Murphy, NP; Hamilton, RM; Lubbers, ER; James, CA; Kline, CF; Gollob, MH; Krahn, AD; Sturm, AC; Musa, H; El-Refaey, M; Koenig, S; et al.